Institutional Ownership Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE). We have compiled data on the 221 institutions that hold shares in the stock, with a total of 73.2 Million shares, which have been reported (via 13F filing form) to have a value of $2.63 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Avoro Capital Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
5,400,000
shares
|
$194 Million
3.08% of portfolio
|
Q2 2025
Reduced 5.95%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
4,335,648
shares
|
$156 Million
1.31% of portfolio
|
Q2 2025
Reduced 5.44%
|
|
Braidwell LP
Stamford, CT |
Aug 14, 2025 Q2 2025 |
3,605,029
shares
|
$130 Million
6.91% of portfolio
|
Q2 2025
Added 33.03%
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
3,577,735
shares
|
$129 Million
0.06% of portfolio
|
Q2 2025
Added 7.6%
|
|
Capital International Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
3,181,549
shares
|
$115 Million
0.02% of portfolio
|
Q2 2025
Added 3.01%
|
|
Commodore Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,025,000
shares
|
$109 Million
8.83% of portfolio
|
Q2 2025
Added 30.11%
|
|
Polar Capital Holdings PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
2,703,256
shares
|
$97.3 Million
0.49% of portfolio
|
Q2 2025
Added 3.06%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,174,761
shares
|
$78.3 Million
0.01% of portfolio
|
Q2 2025
Reduced 42.61%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,095,894
shares
|
$75.4 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.23%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,032,730
shares
|
$73.2 Million
0.09% of portfolio
|
Q2 2023
Added 1.42%
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,000,000
shares
|
$72 Million
3.3% of portfolio
|
Q2 2025
Added 53.85%
|
|
Holocene Advisors, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,809,475
shares
|
$65.1 Million
0.15% of portfolio
|
Q2 2025
New holding
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
1,518,527
shares
|
$54.7 Million
0.02% of portfolio
|
Q2 2025
Added 14.23%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
1,474,449
shares
|
$53.1 Million
0.05% of portfolio
|
Q2 2025
Reduced 0.21%
|
|
Westfield Capital Management CO LP
Boston, MA |
May 09, 2025 Q1 2025 |
1,391,370
shares
|
$50.1 Million
0.24% of portfolio
|
Q1 2025
Added 20.24%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,380,460
shares
|
$49.7 Million
0.0% of portfolio
|
Q2 2025
Added 351.69%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,357,602
shares
|
$48.9 Million
0.0% of portfolio
|
Q1 2025
Added 0.05%
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
1,350,000
shares
|
$48.6 Million
1.5% of portfolio
|
Q2 2025
Added 35.0%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,290,100
shares
|
$46.4 Million
0.07% of portfolio
|
Q2 2025
Reduced 32.62%
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
1,100,000
shares
|
$39.6 Million
5.78% of portfolio
|
Q2 2025
Reduced 17.18%
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
1,020,254
shares
|
$36.7 Million
0.04% of portfolio
|
Q2 2025
Added 34.57%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
970,343
shares
|
$34.9 Million
0.0% of portfolio
|
Q2 2025
Added 1294.23%
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
947,877
shares
|
$34.1 Million
1.06% of portfolio
|
Q4 2024
Added 4.0%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
931,681
shares
|
$33.5 Million
1.98% of portfolio
|
Q1 2025
Reduced 25.58%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
882,835
shares
|
$31.8 Million
0.01% of portfolio
|
Q2 2025
Added 277.19%
|